A New Jersey Superior Court judge helped negotiate a deal between Stryker and thousands of patients who brought suit against the company for defective hip implants. Stryker manufactured metal-on-metal implants that corroded and required patients to have surgery to remove the hip implants only a few years after receiving it in the first place. The new deal will require Stryker to pay $1.43 billion to the patients to compensate for their repeat surgeries and injuries caused by the implants. A year ago, Johnson & Johnson paid $2.5 billion in 8,000 lawsuits brought against the company for the same hip implant issue. After the last few years of discovering the implants to be defective, a study conducted by British researchers determined that metal-on-metal hip implants should not be used in any circumstance. Within five years of receiving the implant, 6% of patients needed surgery to fix or replace the implant, compared to 1.7% of patients receiving ceramic implants and 2.3% of patients receiving plastic implants. After the British study concluded, the FDA concurred with the results and said metal-on-metal implants should no longer be used.